Matrix metalloproteinases (MMPs) were primarily responsible for the degradation of extracellular matrix (ECM) in vivo, with MMP-2 and MMP-9 being key markers of AAA (Li et al., 2020b). The gene discussed is MMP9; the disease is triple-A syndrome.